“Phase I Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic Keratosis”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s119. Accessed April 19, 2026. https://skin.dermsquared.com/skin/article/view/1092.